Novo Nordisk Pharmatech makes first sales agreement in Mexico
Helm de México is a new ally for the company.
by andreas lønstrup, translated by catherine brett
Novo Nordisk Pharmatech has entered into an agreement with Helm de México, which will be responsible for the distribution of Novo's Quats (synthetic molecules) in Mexico.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
